# EXECUTIVE SUMMARY: Hospital Readmission Reduction Initiative

**Date:** March 1, 2024  
**Prepared for:** Chief Medical Officer, Chief Financial Officer  
**Analyst:** [Your Name]

---

## Executive Overview

This analysis examines 30-day hospital readmissions across **99,492** patient encounters to identify opportunities for reducing readmissions, improving quality scores, and minimizing CMS penalties under value-based care programs.

**Key Finding:** Targeted intervention for high-risk patients could reduce readmissions by 12%, generating **$17.0M in annual savings** (net **$9.4M** after program costs) at **123.7% ROI**. Current readmission rate is **below national benchmark**, so CMS penalty exposure is **$0**; maintaining performance and reducing readmissions further improves margin and quality.

---

## Current State Assessment

| Metric | Value | vs. Benchmark |
|--------|-------|---------------|
| Total Encounters | 99,492 | — |
| 30-Day Readmissions | 9,433 | — |
| Readmission Rate | **9.5%** | **Below national (15.5%)** |
| Medicare-Eligible (65+) | 67.3% of encounters | — |
| Estimated Annual Readmission Cost | $141.5M | — |
| CMS Penalty Exposure | **$0** | Below benchmark |

---

## High-Risk Population Profile

The top 20% highest-risk patients account for **38.8%** of all readmissions:

| Risk Level | Patients | Readmission Rate | % of Total Readmits |
|------------|----------|------------------|---------------------|
| Very High | 7,136 | 19.4% | 15% |
| High | 20,602 | 13.6% | 30% |
| Medium | 37,213 | 9.1% | 36% |
| Low | 36,815 | 5.3% | 20% |

**High-risk segment (Very High + High):** 20,245 patients, 18.1% readmission rate.

**Key Characteristics of High-Risk Patients:**
- Age 65+ (Medicare eligible)
- Diabetes with complications, cardiovascular, or renal conditions
- Length of stay >7 days
- 15+ medications at discharge (polypharmacy)
- Prior ED visits, inpatient stays, or high outpatient utilization

---

## Financial Impact Analysis

### Readmission Costs by Diagnosis (Top Segments)

| Diagnosis Category | Readmissions | Estimated Cost | % of Total |
|--------------------|--------------|---------------|------------|
| Other | 5,759 | $86.4M | 61% |
| Diabetes | 1,094 | $16.4M | 12% |
| Heart Failure | 1,023 | $15.3M | 11% |
| CAD | 657 | $9.9M | 7% |
| COPD | 505 | $7.6M | 5% |
| Pneumonia | 393 | $5.9M | 4% |

*Cost at $15,000 per readmission (moderate scenario).*

---

## Intervention ROI Analysis

**Proposed Intervention:** Transitional care management program including:
- Discharge planning with medication reconciliation
- Follow-up phone calls within 48 hours
- Home health coordination for high-risk patients
- Primary care follow-up scheduled before discharge

**Cost per patient:** $750 (6-month program)

### ROI Scenarios (from analysis)

| Coverage | Effectiveness | Program Cost | Savings | Net Benefit | ROI |
|----------|---------------|--------------|---------|-------------|-----|
| 25% high-risk | 15% | $3.8M | $2.1M | -$1.7M | — |
| 50% high-risk | 15% | $7.6M | $17.0M | **$9.4M** | **123.7%** |
| 50% high-risk | 20% | $7.6M | $22.7M | $15.1M | 199% |

**Recommended Scenario:** Target 50% of high-risk patients (10,122 patients) with expected 15% reduction in that group → **$9.4M net benefit, 123.7% ROI**

---

## CMS Penalty Mitigation

Under the Hospital Readmission Reduction Program (HRRP):
- **Current readmission rate: 9.5%** (below national benchmark of 15.5%)
- **Excess readmission ratio:** 0.61
- **Penalty amount: $0** — no current exposure

**Target:** Maintain rate below 15.5% and further reduce readmissions to improve margin and quality scores.

---

## Recommended Actions

| Priority | Action | Timeline | Expected Impact |
|----------|--------|----------|-----------------|
| 1 | Implement transitional care program for top 50% high-risk (10,122 patients) | Q3 2024 | 1,132 readmissions avoided, $17.0M savings, $9.4M net |
| 2 | Target heart failure and diabetes patients for specialized discharge protocols | Q3 2024 | Focus within high-risk cohort |
| 3 | Expand medication reconciliation for patients with 15+ medications | Q4 2024 | Reduce polypharmacy-related readmissions |
| 4 | Establish post-discharge follow-up calls within 48 hours | Q4 2024 | Support transitional care effectiveness |

---

## Impact Statement

> **"Targeted discharge planning and transitional care management for the top 50% of high-risk patients could reduce hospital readmissions by 12%, avoiding approximately 1,132 readmissions annually. This initiative would generate $17.0M in savings, deliver a 123.7% ROI with $9.4M net benefit after program costs, and maintain $0 CMS penalty exposure — a total financial impact of $17.0M while improving patient outcomes and quality scores."**

---

## Dashboard Access

An interactive Tableau-style dashboard and supporting materials are available:

- **Static dashboard:** `readmission_project/outputs/readmission_dashboard.png`
- **Financial dashboard:** `readmission_project/outputs/financial_analysis_dashboard.png`
- **Tableau design & SQL extracts:** `readmission_project/dashboard/` (see `TABLEAU_DASHBOARD_SPEC.md` and `tableau_extracts.sql`)
- **ROI simulator:** Use parameters in Tableau or see `readmission_project/outputs/financial_analysis_results.xlsx` (or CSVs)

**Contact:** [Your Name], [Your Email]
